ClearPoint Neuro
CLPT
86 hedge funds and large institutions have $38M invested in ClearPoint Neuro in 2024 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 19 increasing their positions, 21 reducing their positions, and 17 closing their positions.
34% more call options, than puts
Call options by funds: $232K | Put options by funds: $173K
29% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 17
6% more funds holding
Funds holding: 81 → 86 (+5)
10% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 21
2.21% less ownership
Funds ownership: 27.94% → 25.73% (-2.2%)
26% less capital invested
Capital invested by funds: $51.3M → $38M (-$13.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$2.34M |
| 2 |
Renaissance Technologies
New York
|
+$834K |
| 3 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$768K |
| 4 |
Jane Street
New York
|
+$730K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$638K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$6.41M |
| 2 |
State Street
Boston,
Massachusetts
|
-$1.66M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.33M |
| 4 |
AIC
AWM Investment Company
New York
|
-$894K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$529K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AWM
101
Avior Wealth Management
Omaha,
Nebraska
| – | -$27 | -4 | Closed |
|
102
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | +$75 | +13 | New |
|
CLPT Hedge Fund Activity: Q2 2024 in Review
86 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q2 2024, worth a combined $38M — down 26% from $51.3M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new CLPT positions and 17 closed out — a net gain of 5 holders — while 19 added to existing stakes and 21 trimmed.
The largest buyer was Millennium Management, adding an estimated $2.34M. The largest seller was BlackRock, cutting an estimated $6.41M.
- 86 institutional investors held ClearPoint Neuro (CLPT) as of Q2 2024, up from 81 in Q1 2024.
- Funds reported $38M of ClearPoint Neuro stock for Q2 2024, down 26% quarter-over-quarter.
- 22 funds opened new ClearPoint Neuro positions in Q2 2024 and 17 closed out, a net change of +5 holders.
- The largest ClearPoint Neuro buyer in Q2 2024 was Millennium Management, an estimated $2.34M added.
- The largest ClearPoint Neuro seller in Q2 2024 was BlackRock, an estimated $6.41M sold.
Based on aggregated 13F filings for Q2 2024.